CLINICAL_TRIALS
trial_result
· 2017-01-23
Clinical Trial Update: Lamotrigine Phase III Study in Bipolar I Disorder [Phase 3]
Summary
This update reports the completion of a Phase 3 trial evaluating lamotrigine in Bipolar Disorder, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2017-01-23